The Best Foods, Nutrients, Nutraceuticals & Peptides for the 5 Most Common Gene Polymorphisms Affecting Insulin Sensitivity
- Dr Michael Elliott MSc, D.C., CFMP.
- 5 days ago
- 3 min read

Genetics play a major role in how well we regulate blood sugar. Variations in genes related to insulin receptors, glucose transport, inflammation, lipid handling, and mitochondrial function can increase the risk of insulin resistance—even in people who eat well and stay active.
Five of the most clinically relevant polymorphisms affecting insulin sensitivity include variations in:
IRS1 (insulin receptor substrate)
PPARG (fat metabolism & insulin signalling)
SLC2A4 / GLUT4 (glucose transport into muscle)
FTO (appetite regulation & metabolic risk)
TCF7L2 (beta-cell insulin secretion)
Fortunately, targeted foods, nutrients, nutraceuticals, and even peptides can help optimise these pathways and support better glucose control, metabolic resilience, and hormone balance.
Below is a practical breakdown your patients can easily follow.
1. The Top Three Foods for Insulin Sensitivity
1. Blueberries
Rich in anthocyanins, blueberries enhance GLUT4 translocation in muscle cells and improve skeletal muscle insulin signalling—especially in carriers of IRS1 and FTO polymorphisms. Studies show measurable improvements in insulin sensitivity within 6–8 weeks.
2. Extra Virgin Olive Oil
A key component of the Mediterranean diet, EVOO improves PPARG activation, reduces inflammation, and enhances beta-cell function. Its polyphenols directly influence genes related to lipid handling and insulin sensitivity.
3. Cinnamon (Ceylon)
Cinnamon mimics insulin at the receptor level and enhances glucose uptake. It is particularly effective for people with TCF7L2 and IRS1 variations where insulin signalling is sluggish.
2. Three Key Nutrients for Supporting Genetic Insulin Pathways
1. Magnesium
Magnesium is essential for over 300 enzymatic reactions, including insulin receptor activity. Low magnesium amplifies the negative effects of PPARG and FTO polymorphisms, while supplementation improves fasting glucose and HOMA-IR.
2. Vitamin D
Vitamin D enhances insulin receptor expression, reduces inflammatory signalling, and improves beta-cell function—highly relevant for TCF7L2 carriers who struggle with optimal insulin secretion. It also modulates genes linked to metabolic inflammation.
3. Omega-3 Fatty Acids (EPA/DHA)
Omega-3s reduce inflammation, improve adiponectin levels, and support healthy PPARG activity. They stabilize insulin responses and help offset genetic predispositions toward fatty liver and metabolic syndrome.
3. Three Nutraceuticals with Strong Genetic & Metabolic Impact
1. Berberine
Berberine activates AMPK, improves GLUT4 expression, and mimics the effects of metformin. It is especially helpful for individuals with IRS1 and PPARG polymorphisms and has strong evidence for reducing fasting glucose, HbA1c, and central adiposity.
2. Alpha-Lipoic Acid (ALA)
ALA improves mitochondrial function and reduces inflammatory stress, two major drivers of insulin resistance in people with FTO and TCF7L2 variations. It enhances GLUT4 activity and improves nerve health.
3. Myo-Inositol
Myo-inositol improves insulin receptor signalling and reduces hyperinsulinemia. It is valuable for IRS1, TCF7L2, and PPARG polymorphisms and supports hormone balance in both males and females.
4. Three Peptides That Support Insulin Sensitivity
1. MOT-C
MOT-S is a mitochondrial peptide that activates AMPK and improves skeletal muscle glucose uptake. It is particularly effective where mitochondrial dysfunction interacts with FTO or PPARG polymorphisms.
2. Humanin
Humanin improves mitochondrial resilience, reduces oxidative stress, and supports insulin sensitivity at the cellular level. Beneficial in individuals with beta-cell stress or impaired insulin secretion (common in TCF7L2 variations).
3. BPC-157
While best known for gut and tissue repair, BPC-157 improves nitric oxide signalling, reduces inflammation, and enhances metabolic resilience. This indirectly supports insulin sensitivity, especially in inflammatory-driven insulin resistance patterns.
(Note: Peptides discussed are for educational purposes and depend on legal availability in your region.)
Conclusion
Genetic variations affecting insulin sensitivity do not dictate destiny—they guide smarter lifestyle and nutritional choices. By combining targeted foods, key micronutrients, evidence-based nutraceuticals, and emerging peptide therapies, individuals with metabolically unfavourable gene polymorphisms can dramatically improve their insulin sensitivity and long-term metabolic health.


